FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017922054> ?p ?o ?g. }

• W2017922054 endingPage "136" @default.
• W2017922054 startingPage "131" @default.
• W2017922054 abstract "Background– The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial compared dabigatran 110 mg BID (D110) and 150 mg BID (D150) with warfarin for stroke prevention in 18 113 patients with nonvalvular atrial fibrillation. Methods and Results– Cardioversion on randomized treatment was permitted. Precardioversion transesophageal echocardiography was encouraged, particularly in dabigatran-assigned patients. Data from before, during, and 30 days after cardioversion were analyzed. A total of 1983 cardioversions were performed in 1270 patients: 647, 672, and 664 in the D110, D150, and warfarin groups, respectively. For D110, D150, and warfarin, transesophageal echocardiography was performed before 25.5%, 24.1%, and 13.3% of cardioversions, of which 1.8%, 1.2%, and 1.1% were positive for left atrial thrombi. Continuous treatment with study drug for ≥3 weeks before cardioversion was lower in D110 (76.4%) and D150 (79.2%) compared with warfarin (85.5%; P <0.01 for both). Stroke and systemic embolism rates at 30 days were 0.8%, 0.3%, and 0.6% (D110 versus warfarin, P =0.71; D150 versus warfarin, P =0.40) and similar in patients with and without transesophageal echocardiography. Major bleeding rates were 1.7%, 0.6%, and 0.6% (D110 versus warfarin, P =0.06; D150 versus warfarin, P =0.99). Conclusions– This study is the largest cardioversion experience to date and the first to evaluate a novel anticoagulant in this setting. The frequencies of stroke and major bleeding within 30 days of cardioversion on the 2 doses of dabigatran were low and comparable to those on warfarin with or without transesophageal echocardiography guidance. Dabigatran is a reasonable alternative to warfarin in patients requiring cardioversion. Clinical Trial Registration– URL: http://www.ClinicalTrials.gov . Unique identifier: NCT00262600." @default.
• W2017922054 created "2016-06-24" @default.
• W2017922054 creator A5000771121 @default.
• W2017922054 creator A5003780786 @default.
• W2017922054 creator A5005280066 @default.
• W2017922054 creator A5018419311 @default.
• W2017922054 creator A5029533765 @default.
• W2017922054 creator A5038869227 @default.
• W2017922054 creator A5040485133 @default.
• W2017922054 creator A5045613353 @default.
• W2017922054 creator A5051676339 @default.
• W2017922054 creator A5076521291 @default.
• W2017922054 creator A5079046512 @default.
• W2017922054 creator A5081398468 @default.
• W2017922054 creator A5081852908 @default.
• W2017922054 date "2011-01-18" @default.
• W2017922054 modified "2023-10-03" @default.
• W2017922054 title "Dabigatran Versus Warfarin in Patients With Atrial Fibrillation" @default.
• W2017922054 cites W1738640266 @default.
• W2017922054 cites W1804375307 @default.
• W2017922054 cites W1967889750 @default.
• W2017922054 cites W1969928268 @default.
• W2017922054 cites W1974349079 @default.
• W2017922054 cites W2013832146 @default.
• W2017922054 cites W2014679230 @default.
• W2017922054 cites W2018147535 @default.
• W2017922054 cites W2035193897 @default.
• W2017922054 cites W2045556547 @default.
• W2017922054 cites W2056270834 @default.
• W2017922054 cites W2062946016 @default.
• W2017922054 cites W2064428105 @default.
• W2017922054 cites W2075019300 @default.
• W2017922054 cites W2083035480 @default.
• W2017922054 cites W2097692121 @default.
• W2017922054 cites W2111979976 @default.
• W2017922054 cites W2116489124 @default.
• W2017922054 cites W2119473125 @default.
• W2017922054 cites W2124882231 @default.
• W2017922054 cites W2136489990 @default.
• W2017922054 cites W2145018152 @default.
• W2017922054 cites W2172245650 @default.
• W2017922054 cites W2315823767 @default.
• W2017922054 cites W2329793854 @default.
• W2017922054 doi "https://doi.org/10.1161/circulationaha.110.977546" @default.
• W2017922054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21200007" @default.
• W2017922054 hasPublicationYear "2011" @default.
• W2017922054 type Work @default.
• W2017922054 sameAs 2017922054 @default.
• W2017922054 citedByCount "448" @default.
• W2017922054 countsByYear W20179220542012 @default.
• W2017922054 countsByYear W20179220542013 @default.
• W2017922054 countsByYear W20179220542014 @default.
• W2017922054 countsByYear W20179220542015 @default.
• W2017922054 countsByYear W20179220542016 @default.
• W2017922054 countsByYear W20179220542017 @default.
• W2017922054 countsByYear W20179220542018 @default.
• W2017922054 countsByYear W20179220542019 @default.
• W2017922054 countsByYear W20179220542020 @default.
• W2017922054 countsByYear W20179220542021 @default.
• W2017922054 countsByYear W20179220542022 @default.
• W2017922054 countsByYear W20179220542023 @default.
• W2017922054 crossrefType "journal-article" @default.
• W2017922054 hasAuthorship W2017922054A5000771121 @default.
• W2017922054 hasAuthorship W2017922054A5003780786 @default.
• W2017922054 hasAuthorship W2017922054A5005280066 @default.
• W2017922054 hasAuthorship W2017922054A5018419311 @default.
• W2017922054 hasAuthorship W2017922054A5029533765 @default.
• W2017922054 hasAuthorship W2017922054A5038869227 @default.
• W2017922054 hasAuthorship W2017922054A5040485133 @default.
• W2017922054 hasAuthorship W2017922054A5045613353 @default.
• W2017922054 hasAuthorship W2017922054A5051676339 @default.
• W2017922054 hasAuthorship W2017922054A5076521291 @default.
• W2017922054 hasAuthorship W2017922054A5079046512 @default.
• W2017922054 hasAuthorship W2017922054A5081398468 @default.
• W2017922054 hasAuthorship W2017922054A5081852908 @default.
• W2017922054 hasBestOaLocation W20179220541 @default.
• W2017922054 hasConcept C126322002 @default.
• W2017922054 hasConcept C127413603 @default.
• W2017922054 hasConcept C164705383 @default.
• W2017922054 hasConcept C168563851 @default.
• W2017922054 hasConcept C2776301958 @default.
• W2017922054 hasConcept C2777289489 @default.
• W2017922054 hasConcept C2778205648 @default.
• W2017922054 hasConcept C2778810321 @default.
• W2017922054 hasConcept C2779161974 @default.
• W2017922054 hasConcept C2780645631 @default.
• W2017922054 hasConcept C42219234 @default.
• W2017922054 hasConcept C71924100 @default.
• W2017922054 hasConcept C78519656 @default.
• W2017922054 hasConceptScore W2017922054C126322002 @default.
• W2017922054 hasConceptScore W2017922054C127413603 @default.
• W2017922054 hasConceptScore W2017922054C164705383 @default.
• W2017922054 hasConceptScore W2017922054C168563851 @default.
• W2017922054 hasConceptScore W2017922054C2776301958 @default.
• W2017922054 hasConceptScore W2017922054C2777289489 @default.
• W2017922054 hasConceptScore W2017922054C2778205648 @default.
• W2017922054 hasConceptScore W2017922054C2778810321 @default.
• W2017922054 hasConceptScore W2017922054C2779161974 @default.

• next